Agilent Technologies A
NYSE A
$156.34 +2.65 (+1.72%)
As of: Sep 17, 2026 · 3:59 PM EDT

Agilent Technologies (A) Current Deferred Revenue (2009 - 2026)

Agilent Technologies' (A) quarterly Current Deferred Revenue came in at $640.0 million in Q3 2026, up 3.23% year-over-year from $620.0 million in Q3 2025, and down 3.76% quarter-over-quarter from $665.0 million in Q2 2026.

Analysis

Agilent Technologies (A) Current Deferred Revenue (2009 - 2026) Analysis & Trends

Agilent Technologies (A) has reported Current Deferred Revenue for 18 consecutive years, with $640.0 million the latest figure, recorded in Q3 2026.

  • On a quarterly basis, Current Deferred Revenue rose 3.23% year-over-year to $640.0 million in Q3 2026; TTM through Jul 2026 was $640.0 million, a 3.23% increase from a year earlier, with the FY2025 full-year figure at $624.0 million, up 14.71% from the prior year.
  • Current Deferred Revenue was $640.0 million for Q3 2026 at Agilent Technologies, down from $665.0 million in the prior quarter.
  • Over five years, Current Deferred Revenue peaked at $682.0 million in Q1 2026 and troughed at $461.0 million in Q4 2022.
  • A 5-year average of $558.6 million and a median of $524.0 million in 2024 frame the typical range for Current Deferred Revenue.
  • Across the five-year window, Current Deferred Revenue climbed 19.11% in 2022 and climbed 0.19% in 2024, its largest moves.
  • Over 5 years, Current Deferred Revenue stood at $461.0 million in 2022, then grew by 9.54% to $505.0 million in 2023, then grew by 7.72% to $544.0 million in 2024, then gained by 14.71% to $624.0 million in 2025, then gained by 2.56% to $640.0 million in 2026.
  • The last three Current Deferred Revenue figures came in at $640.0 million (Q3 2026), $665.0 million (Q2 2026), and $682.0 million (Q1 2026), per Business Quant data.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Thermo Fisher Scientific 241.68 Bn 237.61 Bn 8.34 Bn
2 Danaher 147.34 Bn 142.99 Bn 3.61 Bn
3 Agilent Technologies 43.34 Bn 41.59 Bn 1.04 Bn
4 Illumina 34.58 Bn 33.41 Bn 770.00 Mn
5 Revvity 16.31 Bn 15.29 Bn 416.87 Mn
6 Bio-Techne 11.28 Bn 11.01 Bn 211.39 Mn
7 Bio-Rad Laboratories 10.16 Bn 8.54 Bn 345.80 Mn
8 Repligen 9.77 Bn 8.75 Bn 110.04 Mn
9 10x Genomics 9.45 Bn 8.90 Bn 112.50 Mn
10 Bruker 9.26 Bn 9.04 Bn 416.00 Mn
Historic Data

Historic Data

Download Data
DateValue
Jul 31, 2026 640.00 Mn
Apr 30, 2026 665.00 Mn
Jan 31, 2026 682.00 Mn
Oct 31, 2025 624.00 Mn
Jul 31, 2025 620.00 Mn
Apr 30, 2025 628.00 Mn
Jan 31, 2025 612.00 Mn
Oct 31, 2024 544.00 Mn
Jul 31, 2024 524.00 Mn
Apr 30, 2024 533.00 Mn
Jan 31, 2024 522.00 Mn
Oct 31, 2023 505.00 Mn
Jul 31, 2023 512.00 Mn
Apr 30, 2023 519.00 Mn
Jan 31, 2023 521.00 Mn
Oct 31, 2022 461.00 Mn
Jul 31, 2022 498.00 Mn
Apr 30, 2022 511.00 Mn
Jan 31, 2022 493.00 Mn
Oct 31, 2021 441.00 Mn